These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

459 related items for PubMed ID: 10704334

  • 1. Enhancement of the basal-level activity of HIV-1 long terminal repeat by HIV-1 nucleocapsid protein.
    Zhang JL, Sharma PL, Crumpacker CS.
    Virology; 2000 Mar 15; 268(2):251-63. PubMed ID: 10704334
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Strict conservation of the retroviral nucleocapsid protein zinc finger is strongly influenced by its role in viral infection processes: characterization of HIV-1 particles containing mutant nucleocapsid zinc-coordinating sequences.
    Gorelick RJ, Gagliardi TD, Bosche WJ, Wiltrout TA, Coren LV, Chabot DJ, Lifson JD, Henderson LE, Arthur LO.
    Virology; 1999 Mar 30; 256(1):92-104. PubMed ID: 10087230
    [Abstract] [Full Text] [Related]

  • 7. HIV-1 nucleocapsid protein activates transient melting of least stable parts of the secondary structure of TAR and its complementary sequence.
    Bernacchi S, Stoylov S, Piémont E, Ficheux D, Roques BP, Darlix JL, Mély Y.
    J Mol Biol; 2002 Mar 29; 317(3):385-99. PubMed ID: 11922672
    [Abstract] [Full Text] [Related]

  • 8. Identification of human cytomegalovirus target sequences in the human immunodeficiency virus long terminal repeat. Potential role of IE2-86 binding to sequences between -120 and -20 in promoter transactivation.
    Yurochko AD, Huong SM, Huang ES.
    J Hum Virol; 1999 Mar 29; 2(2):81-90. PubMed ID: 10225210
    [Abstract] [Full Text] [Related]

  • 9. Possible roles of HIV-1 nucleocapsid protein in the specificity of proviral DNA synthesis and in its variability.
    Lapadat-Tapolsky M, Gabus C, Rau M, Darlix JL.
    J Mol Biol; 1997 May 02; 268(2):250-60. PubMed ID: 9159468
    [Abstract] [Full Text] [Related]

  • 10. Regulation of HIV-1 gene expression by NF-IL6.
    Tesmer VM, Bina M.
    J Mol Biol; 1996 Sep 27; 262(3):327-35. PubMed ID: 8844998
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Anti-HIV agents that selectively target retroviral nucleocapsid protein zinc fingers without affecting cellular zinc finger proteins.
    Huang M, Maynard A, Turpin JA, Graham L, Janini GM, Covell DG, Rice WG.
    J Med Chem; 1998 Apr 23; 41(9):1371-81. PubMed ID: 9554870
    [Abstract] [Full Text] [Related]

  • 13. The C/EBP site in the feline immunodeficiency virus (FIV) long terminal repeat (LTR) is necessary for its efficient replication and is also involved in the inhibition of FIV LTR-directed gene expression by pseudorabies virus ICP4.
    Kawaguchi Y, Tomonaga K, Maeda K, Ono M, Miyazawa T, Kohmoto M, Tohya Y, Mikami T.
    Virology; 1995 Apr 20; 208(2):492-9. PubMed ID: 7747422
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Regulation of NF-kappaB and HIV-1 LTR activity in mouse L cells by ultraviolet radiation: LTR trans-activation in a nonirradiated genome in heterokaryons.
    Miller SC, Taylor A, Watanabe K, Mok K, Torti FM.
    Exp Cell Res; 1997 Jan 10; 230(1):9-21. PubMed ID: 9013701
    [Abstract] [Full Text] [Related]

  • 16. Mutations of the human cytomegalovirus immediate-early 2 protein defines regions and amino acid motifs important in transactivation of transcription from the HIV-1 LTR promoter.
    Yeung KC, Stoltzfus CM, Stinski MF.
    Virology; 1993 Aug 10; 195(2):786-92. PubMed ID: 8337845
    [Abstract] [Full Text] [Related]

  • 17. Activation of the human immunodeficiency virus type I long terminal repeat by 1 alpha,25-dihydroxyvitamin D3.
    Nevado J, Tenbaum SP, Castillo AI, Sánchez-Pacheco A, Aranda A.
    J Mol Endocrinol; 2007 Jun 10; 38(6):587-601. PubMed ID: 17556530
    [Abstract] [Full Text] [Related]

  • 18. Role of glucocorticoid receptor binding sites in the human immunodeficiency virus type 1 long terminal repeat in steroid-mediated suppression of HIV gene expression.
    Mitra D, Sikder SK, Laurence J.
    Virology; 1995 Dec 20; 214(2):512-21. PubMed ID: 8553553
    [Abstract] [Full Text] [Related]

  • 19. NF-kappaB-repressing factor inhibits elongation of human immunodeficiency virus type 1 transcription by DRB sensitivity-inducing factor.
    Dreikhausen U, Hiebenthal-Millow K, Bartels M, Resch K, Nourbakhsh M.
    Mol Cell Biol; 2005 Sep 20; 25(17):7473-83. PubMed ID: 16107696
    [Abstract] [Full Text] [Related]

  • 20. Binding properties of the human immunodeficiency virus type 1 nucleocapsid protein p7 to a model RNA: elucidation of the structural determinants for function.
    Urbaneja MA, Kane BP, Johnson DG, Gorelick RJ, Henderson LE, Casas-Finet JR.
    J Mol Biol; 1999 Mar 19; 287(1):59-75. PubMed ID: 10074407
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.